In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer

Cell Reports Medicine

Eric Leblanc¹  Anne-Sophie Lemaire¹  Isabelle Fournier²  Tristan Cardon³  Marie Duhamel³  Fabrice Narducci³  Firas Kobeissy³  Maxence Wisztorski³  Philippe Saudemont³  Michel Salzet³  Soulaimane Aboulouard³ 

[1] Department of Gynecology Oncology, Oscar Lambret Center, 59000 Lille, France;Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon;Université Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France;

关键词: sentinel lymph nodes;    endometrial cancer;    proteomics;    alternative proteins;    ghost proteome;    protein mutations;   

DOI  :  

来源: DOAJ

【 摘 要 】

Summary: Endometrial cancer (EC) is one of the most common gynecological cancers worldwide. Sentinel lymph node (SLN) status could be a major prognostic factor in evaluation of EC, but several prospective studies need to be performed. Here we report an in-depth proteomics analysis showing significant variations in the SLN protein landscape in EC. We show that SLNs are correlated to each tumor grade, which strengthens evidence of SLN involvement in EC. A few proteins are overexpressed specifically at each EC tumor grade and in the corresponding SLN. These proteins, which are significantly variable in both locations, should be considered potential markers of overall survival. Five major proteins for EC and SLN (PRSS3, PTX3, ASS1, ALDH2, and ANXA1) were identified in large-scale proteomics and validated by immunohistochemistry. This study improves stratification and diagnosis of individuals with EC as a result of proteomics profiling of SLNs.

【 授权许可】

Unknown